Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Hungary Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20075
20081
20091
20111
20151
20171
20193
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Boehringer Ingelheim4
GlaxoSmithKline3
Theravance Biopharma2
UCB Pharma2
Acorda Therapeutics1
Annovis Bio Inc.1
Eisai Limited1
Mundipharma Research GmbH & Co KG1
NeuroDerm Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease21
Parkinsonian Disorders5
Brain Diseases3
Central Nervous System Diseases3
Movement Disorders3
Nervous System Diseases3
Neurodegenerative Diseases3
Dizziness2
Hypotension2
Pure Autonomic Failure2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.